Artificial-intelligence evangelists such as Sam Altman want to reshape the world, but they need mountains of money to do it. That is sparking a modern-day gold rush on Wall Street.

The Gurugram-headquartered company, which is eyeing an initial public offering (IPO) and is in the planning stages, recently ...

Previously, the reading of the Income Tax Act led to proceeds from exits to be considered business income for domestic ...

(Reuters) -Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Private equity will have a more positive 2025 than it's had recent years, and institutional investors will likely turn their ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...

Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...

Bond manager’s $7 billion stake in Venture Global latest sign that traditional asset managers are making inroads investing in ...

Oilfield services provider Baker Hughes said on Thursday it has signed an agreement with Venture Global to support its ...